Notices. DEPARTMENT OF JUSTICE
219 words·~1 min read·
/register/2003/12/02/03-29961A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4410-09-M DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on April 25, 2003, Lifepoint, Inc., 10400 Trademark Street, Rancho Cucamonga, California 91730, made application by renewal to the Drug Enforcement Administration
(DEA)for registration as a bulk manufacturer of the basic classes of controlled substances listed below: Drug Schedule Tetrahydrocannabinols
(7370)I 3,4-Methylenedioxyamphetamine
(7400)I 3,4-Methylenedioxy-N-ethylamphetamine
(7404)I 3,4-Methylenedioxymethamphetamine
(7405)I Amphetamine
(1100)II Methamphetamine
(1105)II phencyclidine
(7471)II Benzoylecogonine
(9180)II Morphine
(9300)II The firm plans to produce small quantities of controlled substances for use in drug test kits. Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the proposed registration. Any such comments or objectives may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: Federal Register Representative, Office of Chief Counsel
(CCD)and must be filed no later than February 2, 2004. Dated: November 14, 2003. Laura M. Nagel, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 03-29961 Filed 12-1-03; 8:45 am]